UnknownNot Applicable

Evaluation of the Multidimensional Dyspnea Profile (MDP)

Germany400 participantsStarted 2018-12-19

Plain-language summary

Aim of this multicenter prospective cohort study is the evaluation of the multidimensional qualities of dyspnea in a number of diseases using the Multidimensional Dyspnea Profile (Banzett et al, ERJ 2015).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * COPD patients with acute exacerbation (Group I) * CHF patients with acute decompensation (group II) * stable COPD patients (group III) * OSA patients with AHI\>15 (group IV) Exclusion Criteria: * Other severe acute diseases that contradict the participation in a clinical trial * Simultaneous participation in another clinical trial * Not capable of giving consent * Language abilities and other disabilities that contradicts the understanding or completing of a clinical questionnaire

What they're measuring

MDP scores during hospital stay

Timeframe: day 1 to day 5

Trial details

NCT IDNCT04090671

SponsorInstitut für Pneumologie Hagen Ambrock eV

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More COPD Exacerbation trials